StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 657.00
-10.00 (-1.50%)
Jun 3, 2026, 3:30 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 6.83 billion as of June 3, 2026. Its market cap has decreased by -51.38% in one year.
Market Cap
6.83B
Enterprise Value
4.86B
Revenue
2.81B
Ranking
n/a
PE Ratio
43.46
Stock Price
657.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 6.83B, a decrease of -67.70%. That is a compound annual growth rate of -20.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 6.83B | -15.89% |
| Dec 30, 2025 | 8.13B | -38.48% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | 21.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 8.06B |
| K Pharma,Inc. | 7.99B |
| MEDINET | 7.77B |
| Kidswell Bio | 7.39B |
| BrightPath Biotherapeutics | 7.30B |
| ADR120S | 7.08B |
| Kubota Pharmaceutical Holdings | 6.46B |
| CellSource | 6.33B |